Figure 3.
Alterations in the progressive motility of sperm treated with increasing concentrations of resveratrol. Semen samples from obese patients with astenospermia (60 cases) were treated with 0–100 µmol/l resveratrol for 30 min, and sperm motility was altered to varying degrees. Exposure to 30 µmol/l resveratrol demonstrated the most notable improvement in progressive motility compared with control and negative control samples. The control and negative control groups were treated with Quinn's Advantage™ Fertilization (HTF) Medium and Quinn's Advantage™ Fertilization (HTF) Medium plus 0.1% dimethyl sulfoxide, respectively.